Product news from the 03/06/07 news brief
Novartis announced that the FDA has approved Tekturna (aliskiren) tablets, the first in a new class of drugs called direct ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.